Evidence map›Paper›PMID 42161945›Full record

ArticleNature communications2026

Glucuronidation metabolomic fingerprinting to map host-microbe metabolism.

Nina R Boyle, Josh J Sekela, Mingxun Wang, Helena Mannochio-Russo, Jeong Joo Pyo, Min Soo Kim, Shuchang Tian, Imhoi Koo, Elliot S Friedman, Ceylan Tanes and 14 more

Abstract read
In one paragraph

Article in Nature communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Pan-Metabolomics Repository Mapping of the Carnitine Landscape.bioRxiv : the preprint server for biology · 2026
    Article
  5. Disrupted terminal bilirubin catabolism linksFrontiers in microbiology · 2026
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

24 authors.

Nina R Boyle *Huck Institutes of the Life Sciences, Pennsylvania State University, University Park, PA, USA.ORCID http://orcid.org/0000-0003-0901-3775
Josh J Sekela *Departments of Chemistry, Biochemistry, Microbiology and Genomics, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
Mingxun WangDepartment of Computer Science, University of California Riverside, Riverside, CA, USA.ORCID http://orcid.org/0000-0001-7647-6097
Helena Mannochio-RussoCollaborative Mass Spectrometry Innovation Center, Skaggs School of Pharmacy and Pharmaceutical Sciences, University of California San Diego, La Jolla, CA, USA.ORCID http://orcid.org/0000-0002-4961-2353
Jeong Joo PyoCurriculum in Toxicology & Environmental Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.ORCID http://orcid.org/0000-0002-7240-021X
Min Soo KimDepartment of Biochemistry and Molecular Biology, Pennsylvania State University, University Park, PA, USA.ORCID http://orcid.org/0000-0002-3322-9448
Shuchang TianDepartment of Biochemistry and Molecular Biology, Pennsylvania State University, University Park, PA, USA.
Imhoi KooCenter for Molecular Toxicology and Carcinogenesis, The Pennsylvania State University, University Park, PA, USA.ORCID http://orcid.org/0000-0002-5816-0627
Elliot S FriedmanDivision of Gastroenterology and Hepatology, Perelman School of Medicine, The University of Pennsylvania, Philadelphia, PA, USA.ORCID http://orcid.org/0000-0003-0050-4965
Ceylan TanesThe Center for Microbial Medicine, Children's Hospital of Philadelphia, Philadelphia, PA, USA.
Mallappa AnithaDepartment of Veterinary and Biomedical Sciences, The Pennsylvania State University, University Park, PA, USA.
Yuan TianHuck Institutes of the Life Sciences, Pennsylvania State University, University Park, PA, USA.
Ethan W MorganCenter for Molecular Toxicology and Carcinogenesis, The Pennsylvania State University, University Park, PA, USA.
Iain A MurrayCenter for Molecular Toxicology and Carcinogenesis, The Pennsylvania State University, University Park, PA, USA.
Joseph P ZackularThe Center for Microbial Medicine, Children's Hospital of Philadelphia, Philadelphia, PA, USA.ORCID http://orcid.org/0000-0002-3228-3055
Kyle BittingerThe Center for Microbial Medicine, Children's Hospital of Philadelphia, Philadelphia, PA, USA.ORCID http://orcid.org/0000-0003-3472-5934
James D LewisCenter for Clinical Epidemiology and Biostatistics, Division of Gastroenterology and Hepatology, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.ORCID http://orcid.org/0000-0003-3107-3862
Gary H PerdewCenter for Molecular Toxicology and Carcinogenesis, The Pennsylvania State University, University Park, PA, USA.
Gary D WuDivision of Gastroenterology and Hepatology, Perelman School of Medicine, The University of Pennsylvania, Philadelphia, PA, USA.ORCID http://orcid.org/0000-0002-1829-8795
Babette S ZemelDivision of Gastroenterology and Hepatology and Nutrition, Department of Pediatrics, Perelman School of Medicine, Children's Hospital of Philadelphia, University of Pennsylvania, Philadelphia, PA, USA.
Pieter C DorresteinCollaborative Mass Spectrometry Innovation Center, Skaggs School of Pharmacy and Pharmaceutical Sciences, University of California San Diego, La Jolla, CA, USA.ORCID http://orcid.org/0000-0002-3003-1030
Jordan E BisanzHuck Institutes of the Life Sciences, Pennsylvania State University, University Park, PA, USA.ORCID http://orcid.org/0000-0002-8649-1706
Matthew R RedinboDepartments of Chemistry, Biochemistry, Microbiology and Genomics, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.ORCID http://orcid.org/0000-0003-0814-5346
Andrew D PattersonHuck Institutes of the Life Sciences, Pennsylvania State University, University Park, PA, USA. adp117@psu.edu.ORCID http://orcid.org/0000-0003-2073-0070

Funding

Phenotypic Diversity in COVID-19UL1TR001878 · NCATS · UNIVERSITY OF PENNSYLVANIA · PI FITZGERALD, GARRET A · 2016 to 2025
$102.4M
TRANSGENIC AND CHIMERIC MOUSE COREP30DK050306 · NIDDK · UNIVERSITY OF PENNSYLVANIA · PI GARY D. WU · 1997 to 2026
$32.5M
Activation of the Ah receptor and epithelial integrityR35ES028244 · NIEHS · PENNSYLVANIA STATE UNIVERSITY, THE · PI PERDEW, GARY H. · 2017 to 2024
$6.2M
Environmental Chemical Impact on the Host-Microbiome InteractionR35ES035027 · NIEHS · PENNSYLVANIA STATE UNIVERSITY, THE · PI Andrew Patterson · 2023 to 2026
$3.6M
Infant Growth and Microbiome Study 2R01DK107565 · NIDDK · CHILDREN'S HOSP OF PHILADELPHIA · PI WU, GARY D., ZEMEL, BABETTE S · 2015 to 2019
$3.6M
Collaborative Microbial Metabolite CenterU24DK133658 · NIDDK · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI PIETER C DORRESTEIN · 2022 to 2026
$2.9M
Molecular interactions in the gut microbiota during early life colonization and perturbationR35GM138369 · NIGMS · CHILDREN'S HOSP OF PHILADELPHIA · PI Joseph Paul Zackular · 2020 to 2026
$2.7M
Gut microbial beta-glucuronidases as a biomarker for mycophenolic acid enterohepatic recirculation and associated toxicitiesR01DK139249 · NIDDK · WEILL MEDICAL COLL OF CORNELL UNIV · PI John Richard Lee · 2024 to 2026
$1.9M
Gut Microbial Enzymes and Human DiseaseR35GM152079 · NIGMS · UNIV OF NORTH CAROLINA CHAPEL HILL · PI Matthew R Redinbo · 2024 to 2026
$1.6M
Decoding Microbial Diversity in the Human Gut MicrobiomeR35GM151045 · NIGMS · PENNSYLVANIA STATE UNIVERSITY, THE · PI Jordan Adam Bisanz · 2023 to 2026
$1.5M
Acquisition of an Orbitrap Fusion Lumos Tribid Mass Spectrometer to Accelerate Metabolite Identification and Pathway AnalysisS10OD021750 · OD · PENNSYLVANIA STATE UNIVERSITY, THE · PI PATTERSON, ANDREW · 2017 to 2017
$966k
Integrative Analysis of Metabolic Phenotypes (IAMP) Predoctoral Training ProgramT32DK120509 · NIDDK · PENNSYLVANIA STATE UNIVERSITY, THE · PI PATTERSON, ANDREW, PERDEW, GARY H. · 2020 to 2024
$781k
NCATS NIH HHS UL1 TR001878NIAID NIH HHS F31 AI183815NIDDK NIH HHS F31 DK134090NIDDK NIH HHS P30 DK050306NIDDK NIH HHS R01 DK107565NIDDK NIH HHS R01 DK139249NIDDK NIH HHS T32 DK120509NIDDK NIH HHS U24 DK133658NIEHS NIH HHS R35 ES028244NIEHS NIH HHS R35 ES035027NIGMS NIH HHS R35 GM138369NIGMS NIH HHS R35 GM151045NIGMS NIH HHS R35 GM152079NIH HHS S10 OD021750United States Department of Agriculture | National Institute of Food and Agriculture (NIFA) Project PEN04607 and Accession number 7000371United States Department of Agriculture | National Institute of Food and Agriculture (NIFA) Project PEN047702 and accession number 7006412U.S. Department of Health & Human Services | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (National Institute of Diabetes & Digestive & Kidney Diseases) 5U24DK133658-02U.S. Department of Health & Human Services | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (National Institute of Diabetes & Digestive & Kidney Diseases) DK139249U.S. Department of Health & Human Services | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (National Institute of Diabetes & Digestive & Kidney Diseases) NIH P30DK050306U.S. Department of Health & Human Services | NIH | National Institute of Environmental Health Sciences (NIEHS) ES028244U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences (NIGMS) GM152079U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences (NIGMS) R35GM138369U.S. Department of Health & Human Services | NIH | NIH Office of the Director (OD) S10OD021750
6 · The paper itself

Abstract

Glucuronidation is an important detoxification pathway that operates in balance with gastrointestinal microbial β-glucuronidase (GUS) activity, which can regenerate bioactive metabolites from their glucuronidated forms. How this host-microbe interaction shapes the distribution and pool of glucuronidated metabolites (i.e., the glucuronidome) remains poorly understood. In this study, we employed pattern-filtering data science approaches in conjunction with untargeted LC-MS/MS metabolomics to map the glucuronidome in urine, serum, and colon/fecal samples from gnotobiotic and conventional mice, and in humans. We find that microbial colonization and GUS activity compress the colonic glucuronidome and expand urinary glucuronidome diversity, revealing a compartmental redistribution of glucuronidated metabolites. Reverse metabolomics of known glucuronidated chemicals and glucuronidation pattern filtering searches in public metabolomics datasets exposed the diversity of glucuronidated metabolites in human and mouse ecosystems. In summary, we present a glucuronidation fingerprint resource that provides broader access to and analysis of the glucuronidome. Together, this work establishes a scalable analytical framework and provides mechanistic insight into how microbial activity reshapes systemic glucuronidation, with implications for drug metabolism, diet-microbe interactions, and biomarker discovery.

Indexed as

Gastrointestinal MicrobiomeGlucuronidesHost Microbial InteractionsMetabolomicsAnimalsChromatography, LiquidColonFecesFemaleGerm-Free LifeGlucuronidaseHumansMaleMetabolomeMiceMice, Inbred C57BLGlucuronidaseGlucuronides

Identifiers

PMID42161945
PMCPMC13381908

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.